LTR Pharma has announced the publication of a third-party validation of its nasal-delivery erectile dysfunction (ED) treatment Spontan (PD 21 May), strengthening LTR’s regulatory dossier as it progresses the drug towards commercialisation.

The post LTR publishes ED clinical study appeared first on Pharmacy Daily.